Cargando…
Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
BACKGROUND: Patients with chronic kidney disease (CKD) are poor candidates for standard treatments for muscle-invasive bladder cancer (MIBC) and may be more likely to experience adverse outcomes when diagnosed with MIBC. OBJECTIVE: To investigate factors associated with the development of advanced C...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738897/ https://www.ncbi.nlm.nih.gov/pubmed/35024629 http://dx.doi.org/10.1016/j.euros.2021.11.001 |
_version_ | 1784629002802036736 |
---|---|
author | Schmidt, Bogdana Velaer, Kyla N. Thomas, I.-Chun Ganesan, Calyani Song, Shen Pao, Alan C. Thong, Alan E. Liao, Joseph C. Chertow, Glenn M. Skinner, Eila C. Leppert, John T. |
author_facet | Schmidt, Bogdana Velaer, Kyla N. Thomas, I.-Chun Ganesan, Calyani Song, Shen Pao, Alan C. Thong, Alan E. Liao, Joseph C. Chertow, Glenn M. Skinner, Eila C. Leppert, John T. |
author_sort | Schmidt, Bogdana |
collection | PubMed |
description | BACKGROUND: Patients with chronic kidney disease (CKD) are poor candidates for standard treatments for muscle-invasive bladder cancer (MIBC) and may be more likely to experience adverse outcomes when diagnosed with MIBC. OBJECTIVE: To investigate factors associated with the development of advanced CKD following radical cystectomy. DESIGN, SETTING, AND PARTICIPANTS: Using national Veterans Health Administration utilization files, we identified 3360 patients who underwent radical cystectomy for MIBC between 2004 and 2018. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We examined factors associated with the development of advanced CKD (estimated glomerular filtration rate [eGFR] of <30 ml/min/1.73 m(2)) after radical cystectomy using multivariable logistic and proportional hazard regression, with and without consideration of competing risks. We examined survival using Kaplan-Meier product limit estimates and proportional hazard regression. RESULTS AND LIMITATIONS: The median age at surgery was 67 yr and the mean preoperative eGFR was 69.1 ± 20.3 ml/min/1.73 m(2). Approximately three out of ten patients (n = 962, 29%) progressed to advanced CKD within 12 mo. Older age (hazard ratio [HR] per 5-yr increase 1.15, 95% confidence interval [CI] 1.10–1.20), preoperative hydronephrosis (HR 1.50, 95% CI 1.29–1.76), adjuvant chemotherapy (HR 1.19, 95% CI 1.00–1.41), higher comorbidity index (HR 1.13, 95% CI 1.11–1.16 per point), and lower baseline kidney function (HR 0.75, 95% CI 0.73–0.78) were associated with the development of advanced CKD. Baseline kidney function at the time of surgery was associated with survival. Generalizability is limited due to the predominantly male cohort. CONCLUSIONS: Impaired kidney function at baseline is associated with progression to advanced CKD and mortality after radical cystectomy. Preoperative kidney function should be incorporated into risk stratification algorithms for patients undergoing radical cystectomy. PATIENT SUMMARY: Impaired kidney function at baseline is associated with progression to advanced chronic kidney disease and mortality after radical cystectomy. |
format | Online Article Text |
id | pubmed-8738897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87388972022-01-11 Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer Schmidt, Bogdana Velaer, Kyla N. Thomas, I.-Chun Ganesan, Calyani Song, Shen Pao, Alan C. Thong, Alan E. Liao, Joseph C. Chertow, Glenn M. Skinner, Eila C. Leppert, John T. Eur Urol Open Sci Bladder Cancer BACKGROUND: Patients with chronic kidney disease (CKD) are poor candidates for standard treatments for muscle-invasive bladder cancer (MIBC) and may be more likely to experience adverse outcomes when diagnosed with MIBC. OBJECTIVE: To investigate factors associated with the development of advanced CKD following radical cystectomy. DESIGN, SETTING, AND PARTICIPANTS: Using national Veterans Health Administration utilization files, we identified 3360 patients who underwent radical cystectomy for MIBC between 2004 and 2018. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We examined factors associated with the development of advanced CKD (estimated glomerular filtration rate [eGFR] of <30 ml/min/1.73 m(2)) after radical cystectomy using multivariable logistic and proportional hazard regression, with and without consideration of competing risks. We examined survival using Kaplan-Meier product limit estimates and proportional hazard regression. RESULTS AND LIMITATIONS: The median age at surgery was 67 yr and the mean preoperative eGFR was 69.1 ± 20.3 ml/min/1.73 m(2). Approximately three out of ten patients (n = 962, 29%) progressed to advanced CKD within 12 mo. Older age (hazard ratio [HR] per 5-yr increase 1.15, 95% confidence interval [CI] 1.10–1.20), preoperative hydronephrosis (HR 1.50, 95% CI 1.29–1.76), adjuvant chemotherapy (HR 1.19, 95% CI 1.00–1.41), higher comorbidity index (HR 1.13, 95% CI 1.11–1.16 per point), and lower baseline kidney function (HR 0.75, 95% CI 0.73–0.78) were associated with the development of advanced CKD. Baseline kidney function at the time of surgery was associated with survival. Generalizability is limited due to the predominantly male cohort. CONCLUSIONS: Impaired kidney function at baseline is associated with progression to advanced CKD and mortality after radical cystectomy. Preoperative kidney function should be incorporated into risk stratification algorithms for patients undergoing radical cystectomy. PATIENT SUMMARY: Impaired kidney function at baseline is associated with progression to advanced chronic kidney disease and mortality after radical cystectomy. Elsevier 2022-01-03 /pmc/articles/PMC8738897/ /pubmed/35024629 http://dx.doi.org/10.1016/j.euros.2021.11.001 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Bladder Cancer Schmidt, Bogdana Velaer, Kyla N. Thomas, I.-Chun Ganesan, Calyani Song, Shen Pao, Alan C. Thong, Alan E. Liao, Joseph C. Chertow, Glenn M. Skinner, Eila C. Leppert, John T. Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer |
title | Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer |
title_full | Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer |
title_fullStr | Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer |
title_full_unstemmed | Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer |
title_short | Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer |
title_sort | renal morbidity following radical cystectomy in patients with bladder cancer |
topic | Bladder Cancer |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738897/ https://www.ncbi.nlm.nih.gov/pubmed/35024629 http://dx.doi.org/10.1016/j.euros.2021.11.001 |
work_keys_str_mv | AT schmidtbogdana renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT velaerkylan renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT thomasichun renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT ganesancalyani renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT songshen renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT paoalanc renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT thongalane renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT liaojosephc renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT chertowglennm renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT skinnereilac renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer AT leppertjohnt renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer |